Re Let , this not be my last wish !

[Guest guest]

Dear FORUM and Umashankar,

Umashankar's case is very compelling, and I assume that there are many others in

the same situation.

Many who just do not have the opportunity to get their posting on to this list.

Many who have never even been to an internet cafe.

I have heard that Kaletra in India is $1380 (US dollars, $1 US is 45 Rupees)

per year from CIPLA , very expensive for anyone who is not wealthy.

It is ironic, because Abbot Laboratories provides its not for profit version of

Kaletra for $500 a year in sub saharan Africa countries, but not in India.

So probably the same would be true for CIPLA if they were willing to sell on a

not for profit basis, in India, meaning $500 a year, perhaps making this

second line drug more affordable for you, and for NACO as well.

But there needs to be political will to get this done.

I will be in India starting on November 5th, and I will hope to bring your case

to the attention of CIPLA, NACO, WHO and UNAIDS, and I will also forward this

correspondence to Abbot Laboratories, whose current price is above $2,000 US

per year.

I am also wondering what specific second line medication your Doctor

recommended (if it was Kaletra or something else) and if you have contacts

who are interested in similar issues that you would recommend in New Delhi where

I will be in November for a couple of weeks.

I hope I can do something to help.

Sincerely,

Stern

e-mail: <rastern@...>